CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 30 enrolled
Drug / intervention
RMBand lower dose +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03799614
NCT03799614N/ACompleted
CompareCT.gov

Vibration Impact on Parkinson's Tremor

Virginia Commonwealth University·interventional·Posted Jan 10, 2019·Updated Dec 17, 2020

In Brief

A clinical study evaluating RMBand lower dose and RMBand higher dose for Parkinson Disease. Completed, enrolled 30 participants across 1 site.

Detailed Summary

The primary purpose of this study is to test the safety, tolerability and efficacy of vibration (delivered by an experimental device called RMBand that is worn on the subject's arm) on parkinsonian tremor. The RMBand was developed by Resonate Forward, LLC (RF). This RMBand is designed to administer a vibration to the wearer to decrease or stop tremor in persons with Parkinson's disease (PD).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsParkinson Disease
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedJan 10, 2019
Enrollment StartFeb 26, 2019
Primary CompletionNov 27, 2019
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 7.5 years ago

Interventions

RMBand lower dosedevice

Light-weight portable device that delivers low dose vibration to the arm

RMBand higher dosedevice

Light-weight portable device that delivers higher dose vibration to the arm